医学
食管
放化疗
小细胞癌
小细胞肺癌
放射治疗
化疗
放射科
全身疗法
癌症分期
肿瘤科
依托泊苷
临床试验
癌
阶段(地层学)
外科
癌症
疾病
生活质量(医疗保健)
围手术期
内科学
吞咽困难
鼻咽癌
活检
食管癌
食道疾病
转移
缓和医疗
杜瓦卢马布
肺癌
普通外科
TNM分期系统
根治性手术
上腔静脉综合征
出处
期刊:PubMed
[National Institutes of Health]
日期:2026-06-23
卷期号:48 (6): 724-737
标识
DOI:10.3760/cma.j.cn112152-20251114-00570
摘要
Small cell carcinoma of the esophagus (SCEC) is a rare and highly aggressive neuroendocrine tumor with poor prognosis. Its clinical manifestations lack specificity, and diagnosis relies on gastroscopic biopsy pathology and immunohistochemistry. The use of ultrasonic gastroscope, enhanced CT or positron emission tomography-computed tomography (PET-CT), and brain MRI is recommended for accurate staging. The American Joint Committee on Cancer-tumor, node, metastasis (AJCC-TNM) staging system and the Veterans Administration Lung Study Group (VALSG) staging systems are adopted to guide the treatment. The treatment emphasizes a multidisciplinary comprehensive mode incorporating chemotherapy, radiotherapy and surgery. For patients with limited-stage disease, chemotherapy combined with local treatment (surgery or radiotherapy) is recommended. For operable patients, radical chemoradiotherapy or perioperative treatment followed by radical surgery is recommended, while patients with inoperable disease should receive radical chemoradiotherapy. For patients with extensive-stage disease, systemic chemotherapy is the mainstay, while etoposide plus platinum as the preferred regimen. If systemic treatment is effective, additional local treatment may be administered for residual lesions. Palliative treatment is recommended for symptomatic metastases. There is currently a lack of high-level evidence-based medical evidence for immunotherapy, and relevant clinical trials are recommended. This consensus aims to promote the standardized diagnosis and treatment of SCEC and to improve patients' quality of life and long-term survival through multidisciplinary collaboration.
科研通智能强力驱动
Strongly Powered by AbleSci AI